BioCatch, a Tel Aviv, Israel-based company specializing in software for identifying and preventing bank fraud and money laundering, secured around $70 million in funding, bringing its total raised to $253 million to date.
SaaS Investors
The investment was from Sapphire Ventures, valuing the BioCatch at over $1 billion. This funding occurred one day before a significant event involving Hamas.
Sapphire Ventures is a venture capital firm with offices in Menlo Park, San Francisco, Austin, and London. Founded in 2011, the firm prefers to invest in companies operating in the b2b SaaS, artificial intelligence, machine learning, crypto, cybersecurity, data analytics devOps, finance technology, health technology, and vertical software as service sectors.
About BioCatch
Led by CEO Gadi Mazor, founded in 2011, BioCatch is a cybersecurity company that delivers behavioral biometrics, analyzing human-device interactions to protect users and data. Its mission is to unlock the power of behavior and deliver actionable insights to create a digital world where identity, trust, and ease seamlessly co-exist. With over a decade of analyzing data, over 60 patents, and unparalleled experience, BioCatch continues to innovate to solve tomorrow’s problems.
Funding Details
Company: BioCatch Ltd.
Raised: $70.0M
Round: Unknown
Funding Month: November 2023
Lead Investors: Sapphire Ventures
Additional Investors:
Company Website: https://www.biocatch.com/
Software Category: Cybersecurity
Source: https://www.promyze.com/promyze-secures-1m-in-seed-funding-to-reinvent-knowledge-sharing-for-developers/